SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (4612)4/15/1998 8:48:00 AM
From: Biomaven  Read Replies (1) of 9719
 
V1,

<<I have taken a look at the financing and frankly its not as bad as people have made out. First it must be converted within 3 years. Second, until December 20 of this year the conversion price is not less than $14.55 a share. GZTC is obviouly betting on a sucessfull phase III before the end of the year which will drive the stock price in excess of $14. >>

I agree that this is not as bad as the "convert at 75% of the then price" financings, and that you do have protection until Dec 20. The issue is that any time after Dec 20, the holders have every incentive to deliberately drive down the price on 5 days of their choosing, so as to get good terms for their conversion, even if the price is then above $14.55. (Unless you take the view that this would be an illegal manipulation of the stock price). In other words, they would sell (short) say 1/3 of their holding at below the market price so as to get the same price for their entire conversion. The net effect is that the financing would be more dilutive than it appears to be.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext